FDA Inspection 1002473 — Nesher Pharmaceuticals (USA) LLC

Nesher Pharmaceuticals (USA) LLC — FEI 1922352

The FDA completed an inspection of Nesher Pharmaceuticals (USA) LLC on Feb 3, 2017 in Bridgeton, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 3, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bridgeton, MO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.